profit from every $100 of sales.
$0$100
GP-Act III Acquisition
$11.09+0.00% today
+3.5% in 1 year
1-year low $10.721-year high $11.69
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $26.13 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What GP-Act III Acquisition sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with $11.9 million of profit last year.
SalesProfit
GP-Act III Acquisition vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| GP-Act III Acquisition | 26.1× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads GP-Act III Acquisition's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -0 | -0 | -1 | -1 | |
| -0 | -0 | -1 | -1 | |
| -0 | -0 | 9 | 12 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1 | 1 | 297 | 309 |
| Cash | 0 | 0 | 0 | 0 |
| Total debt | 0 | 1 | 0 | 0 |
| Total liabilities | 1 | 1 | 15 | 15 |
| -0 | -0 | 283 | 295 | |
| – | – | – | – | |
| -6.4% | -2.1% | -0.2% | -0.1% | |
| 36.8% | 14.3% | 3.1% | 4.0% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -0 | -0 | -1 | -0 | |
| – | – | – | – | |
| -0 | -0 | -1 | -0 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 26.1×
- –
- 0.70
- 1.1×
- 0.0×
- –
- –
- -0.1%
- 3.8%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -0.2%
- -1.3%
- 4.1%
- 3.8%
- -0.2%
- –
Growth
- –
- –
- +36.3%
- –
- −2.1%
Financial health
- -0.5×
- 0.00
- 0.1%
- –
- 0.30
- 0.30
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 12%of 754
Bottom 7%of 605
Bottom 22%of 883
Bottom 26%of 929
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | 0.06 | – | – |
| Mar 26, 2026 | 0.08 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
21No pass
Benjamin Graham
47No pass
Philip Fisher
39No pass
Peter Lynch
60Pass
Joel Greenblatt
9No pass
Charlie Munger
27No pass
Terry Smith
23No pass
Questions about GP-Act III Acquisition
Is GP-Act III Acquisition a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the GP-Act III Acquisition AI analysis
What does GP-Act III Acquisition do?
GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. It is in Shell Companies.
Does GP-Act III Acquisition pay a dividend?
No. GP-Act III Acquisition does not pay a dividend at the moment.
Is GP-Act III Acquisition stock halal?
Questionable. GP-Act III Acquisition sits in a grey zone: scholars disagree about its industry. How we check
How has GP-Act III Acquisition stock done over the past year?
Up 3.5% over the past twelve months, to $11.09. It traded between $10.72 and $11.69 and is 5.1% below its high.
Who are GP-Act III Acquisition's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with GP-Act III Acquisition's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.